Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, ...
May 19, 2021
0
3